Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
Products
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 

Gynapill ® Taj Products

 
HOME >> PRODUCTS >> Taj Products >> Gynapill
Taj  ALL Products View Products According to Category


Each film-coated tablet contains
Composition

Levonorgestrel I.P....................................................0.75 mg

Indications
The Leading Emergency Contraceptive Pill in India
Emergency Contraception consists of the administration of a hormonal product within 72 hours after a unprotected sexual intercourse to prevent pregnancy.

Description
Levonorgestrel belongs to the class of Progestogens, it is a synthetic steroid and mostly used as regular oral contraception.

Levonorgestrel emergency contraceptive pills (ECPs) have been shown to prevent ovulation and they did not have any detectable effect on the endometrium (uterine lining) or progesterone levels when given after ovulation. ECPs are not effective once the process of implantation has begun, and will not cause abortion.

The few studies that have looked at levonorgestrel`s mechanisms of action in postcoital contraception suggest that it may affect both follicle growth and development of the corpus luteum (the progesterone-secreting tissue that forms in the ovary immediately after ovulation).
When 0.75 mg of Levonorgestrel administered for four days either before ovulation, around the time of ovulation or after ovulation, indicated that the impact of Levonorgestrel depends on the time of administration. When Levonorgestrel was given during the early follicular phase, the total cycle length was significantly prolonged due to the increased duration of the follicular phase.

Post treatment biopsies taken on cycle days 20-22 still showed proliferative endometrium in accordance with the delay in ovulation. When levonorgestrel was administered around the time of ovulation, the effects were variable: Ovulation was blocked in some women, while in others follicular activity was followed by deficient luteal function, and still other women ovulated normally. On the other hand, administering levonorgestrel during the luteal phase did not affect cycle length or cause any significant endometrial changes. This last finding was somewhat unexpected in view of the proven effectiveness of levonorgestrel in emergency contraception.
WARNING: this method can prevent an undesired pregnancy but it does not protect against STDs and AIDS.

Dosage
The first tablet must be taken as soon as possible after unprotected intercourse, and within 72 hours (3 days) at the latest after intercourse. The second tablet must be taken 12 hours at the earliest and 24 hours at the latest after the first one.

Presentations
2 tablets

 


Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).


 

 



gynapill products

 

 



 










 

 

 

 

 

 

              
 Print page   Send by mail





 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`  

 

 

 

 

 

 

 


 

 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement